TOMOPHASE OCTIS— 510(k) K102599
Substantially EquivalentTomophase Corporation
FDA 510(k) clearance K102599 for TOMOPHASE OCTIS, Substantially Equivalent on 2010-12-01. Applicant: Tomophase Corporation.
Clearance details
- Applicant
- Tomophase Corporation
- Product code
- Code NQQ
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Hampton, NH, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.